WILDE; Richard G.

Patent Applications and Registrations

Patent applications and USPTO patent grants for WILDE; Richard G..The latest application filed is for "methods for the production of functional protein from dna having a nonsense mutation and the treatment of disorders associated therewith".

Company Profile

0.18.18

WILDE; Richard G. - Somerville NJ
Wilde; Richard G. - Newark DE
Wilde, Richard G. - US
Wilde; Richard G. - New Castle DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods For The Production Of Functional Protein From Dna Having A Nonsense Mutation And The Treatment Of Disorders Associated Therewith App 20160199357 - ALMSTEAD; Neil ; et al.	2016-07-14
Methods for the production of functional protein from DNA having a nonsense mutation and the treatment of disorders associated therewith Grant 9,289,398 - Almstead , et al. March 22, 2	2016-03-22
Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease Grant 8,334,313 - Wilde , et al. December 18, 2	2012-12-18
Ureido Substituted Benzoic Acid Compounds And Their Use For Nonsense Suppression And The Treatment Of Disease App 20110130391 - Wilde; Richard G. ; et al.	2011-06-02
Pyrrolinone Compounds As Inhibitors Of Bacterial Peptidyl Trna Hydrolase And Uses Thereof App 20110130397 - Choi; Soongyu ; et al.	2011-06-02
Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease Grant 7,902,241 - Wilde , et al. March 8, 2	2011-03-08
Methods For The Production Of Functional Protein From Dna Having A Nonsense Mutation And The Treatment Of Disorders Associcated Therewith App 20110046136 - Almstead; Neil G. ; et al.	2011-02-24
Use of Acetylamino benzoic acid compounds for nonsense suppression and the treatment of disease Grant 7,763,656 - Wilde , et al. July 27, 2	2010-07-27
Heterocyclic Inhibitors Of Bacterial Peptidyl Trna Hydrolase And Uses Thereof App 20100069380 - Choi; Soongyu ; et al.	2010-03-18
Use of nucleoside compounds for nonsense suppression and the treatment of genetic diseases Grant 7,449,570 - Wilde , et al. November 11, 2	2008-11-11
Ureido Substituted Benzoic Acid Compounds And Their Use For Nonsense Suppression And The Treatment Of Disease App 20080275233 - Wilde; Richard G. ; et al.	2008-11-06
Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease Grant 7,405,233 - Wilde , et al. July 29, 2	2008-07-29
Nucleoside compounds and their use for treating cancer and diseases associated with somatic mutations App 20080090774 - Wilde; Richard G. ; et al.	2008-04-17
Nucleoside compounds and their use for treating cancer and diseases associated with somatic mutations Grant 7,291,603 - Wilde , et al. November 6, 2	2007-11-06
Use of acetylamino benzoic acid compounds for nonsense suppression and the treatment of disease App 20070203123 - Wilde; Richard G. ; et al.	2007-08-30
Acetylamino benzoic acid compounds and their use for nonsense suppression and the treatment of disease Grant 7,247,741 - Wilde , et al. July 24, 2	2007-07-24
Use of nucleoside compounds for nonsense suppression and the treatment of genetic diseases App 20060166926 - Wilde; Richard G. ; et al.	2006-07-27
Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease App 20060167065 - Wilde; Richard G. ; et al.	2006-07-27
Acetylamino benzoic acid compounds and their use for nonsense suppression and the treatment of disease App 20060167263 - Wilde; Richard G. ; et al.	2006-07-27
Imidazopyrimidinyl and imidazopyri dinyl derivatives Grant 7,045,529 - Wilde , et al. May 16, 2	2006-05-16
Pyrazolotriazines as CRF antagonists Grant 7,026,317 - Gilligan , et al. April 11, 2	2006-04-11
Pyrazolotriazines as CRF antagonists Grant 6,960,583 - Gilligan , et al. November 1, 2	2005-11-01
Pyrazolopyrimidines as CRF antagonists Grant 6,958,341 - Wilde , et al. October 25, 2	2005-10-25
Novel imidazopyrimidinyl and imidazopyri dinyl derivatives App 20040229887 - Wilde, Richard G. ; et al.	2004-11-18
Pyrazolotriazines as CRF antagonists App 20040176376 - Gilligan, Paul J. ; et al.	2004-09-09
Nucleoside compounds and their use for treating cancer and diseases associated with somatic mutations App 20040067900 - Wilde, Richard G. ; et al.	2004-04-08
Imidazo[1, 2-a] pyrazines for the treatment of irritable bowel syndrome App 20030220342 - Bakthavatchalam, Rajagopal ; et al.	2003-11-27
Pyrazolopyrimidines as CRF antagonists App 20030139426 - Wilde, Richard G. ; et al.	2003-07-24
Imidazo[1,2-a]pyrazines for the treatment of neurological disorders Grant 6,589,952 - Bakthavatchalam , et al. July 8, 2	2003-07-08
Pyrazolotriazines as CRF antagonists App 20020147338 - Gilligan, Paul J. ; et al.	2002-10-10
Imidazo[1,2-a]pyrazines for the treatment of neurological disorders App 20020049208 - Bakthavatchalam, Rajagopal ; et al.	2002-04-25
Derivatives of cyclic ethers and sulfides for the treatment of atherosclerosis Grant 5,491,152 - Wilde , et al. February 13, 1	1996-02-13
Imidazoles linked to bicyclic heterocyclic groups for the treatment of atherosclerosis Grant 5,364,875 - Wilde November 15, 1	1994-11-15
Heterocycle-substituted amides, carbamates and ureas as agents for the treatment of atherosclerosis Grant 5,358,946 - Wilde October 25, 1	1994-10-25
Benzimidazoles for the treatment of atherosclerosis Grant 5,290,801 - Higley , et al. March 1, 1	1994-03-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.